COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]

Detalles Bibliográficos
Autores principales: Churiso, Gemechu, Diriba, Kuma, Girma, Henok, Tafere, Soressa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Response to Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013711/
https://www.ncbi.nlm.nih.gov/pubmed/35444433
http://dx.doi.org/10.2147/IDR.S368827
_version_ 1784688055347576832
author Churiso, Gemechu
Diriba, Kuma
Girma, Henok
Tafere, Soressa
author_facet Churiso, Gemechu
Diriba, Kuma
Girma, Henok
Tafere, Soressa
author_sort Churiso, Gemechu
collection PubMed
description
format Online
Article
Text
id pubmed-9013711
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90137112022-04-19 COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter] Churiso, Gemechu Diriba, Kuma Girma, Henok Tafere, Soressa Infect Drug Resist Response to Letter Dove 2022-04-13 /pmc/articles/PMC9013711/ /pubmed/35444433 http://dx.doi.org/10.2147/IDR.S368827 Text en © 2022 Churiso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Churiso, Gemechu
Diriba, Kuma
Girma, Henok
Tafere, Soressa
COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title_full COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title_fullStr COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title_full_unstemmed COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title_short COVID-19 Clinical Features and Recovery Time: Factors Affecting the Outcome in Infection and Drug Resistance [Response to Letter]
title_sort covid-19 clinical features and recovery time: factors affecting the outcome in infection and drug resistance [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013711/
https://www.ncbi.nlm.nih.gov/pubmed/35444433
http://dx.doi.org/10.2147/IDR.S368827
work_keys_str_mv AT churisogemechu covid19clinicalfeaturesandrecoverytimefactorsaffectingtheoutcomeininfectionanddrugresistanceresponsetoletter
AT diribakuma covid19clinicalfeaturesandrecoverytimefactorsaffectingtheoutcomeininfectionanddrugresistanceresponsetoletter
AT girmahenok covid19clinicalfeaturesandrecoverytimefactorsaffectingtheoutcomeininfectionanddrugresistanceresponsetoletter
AT taferesoressa covid19clinicalfeaturesandrecoverytimefactorsaffectingtheoutcomeininfectionanddrugresistanceresponsetoletter

Ejemplares similares